Published in Immunol Lett on May 01, 2000
Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice. Shock (2004) 1.22
Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS One (2013) 1.12
CD4+ cells are required for chronic eosinophilic lung inflammation but not airway remodeling. Am J Physiol Lung Cell Mol Physiol (2008) 1.07
Correlation of c-erbB-2 and S-100 expression with the malignancy grading and anatomical site in oral squamous cell carcinoma. Int J Exp Pathol (2003) 0.89
Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and CD34(+) cells. Cell Mol Immunol (2012) 0.82
Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases. Infect Dis Ther (2014) 0.82
Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med (1996) 5.29
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods (1996) 4.87
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med (1999) 4.20
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods (1999) 3.09
Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity (2000) 2.93
Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med (1990) 2.21
Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci U S A (1997) 1.85
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J Immunol (2000) 1.32
Human decidua contains potent immunostimulatory CD83(+) dendritic cells. Am J Pathol (2000) 1.24
Listeria monocytogenes-infected human dendritic cells: uptake and host cell response. Infect Immun (2000) 1.14
Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood (2000) 1.13
A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J Gen Virol (2000) 1.10
Dendritic cells: multi-lineal and multi-functional. Immunol Today (2000) 1.10
Migration of dendritic cells within 3-D collagen lattices is dependent on tissue origin, state of maturation, and matrix structure and is maintained by proinflammatory cytokines. J Leukoc Biol (2000) 1.08
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer. Gene Ther (2009) 1.05
Migration of dendritic cells in 3D-collagen lattices. Visualisation of dynamic interactions with the substratum and the distribution of surface structures via a novel confocal reflection imaging technique. Adv Exp Med Biol (1997) 1.05
Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer (2002) 1.03
Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis. Blood (2000) 1.01
[Malignant melanoma of the lacrimal sac]. Ophthalmologe (2008) 0.95
MHC class II and CD40 play opposing roles in dendritic cell survival. Eur J Immunol (2000) 0.95
Antigen processing in populations of mature murine dendritic cells is caused by subsets of incompletely matured cells. J Immunol (1995) 0.94
Antibodies against listerial protein 60 act as an opsonin for phagocytosis of Listeria monocytogenes by human dendritic cells. Infect Immun (2001) 0.94
Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progression. Int J Cancer (2001) 0.93
Murine epidermal Langerhans cells as a model to study tissue dendritic cells. Adv Exp Med Biol (1993) 0.92
CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes. J Immunol (2000) 0.92
Interaction of Neisseria meningitidis with human dendritic cells. Infect Immun (2001) 0.91
Classical chemotherapy for metastatic melanoma. Clin Exp Dermatol (2000) 0.89
Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development. Cell Death Differ (2000) 0.86
Effective enrichment of murine epidermal Langerhans cells by a modified(mismatched) panning technique. J Invest Dermatol (1992) 0.86
Sequential interferon-alpha2b, interleukin-2 and fotemustine for patients with metastatic melanoma. Melanoma Res (2000) 0.83
Dendritic cell production of cytokines and responses to cytokines. Int Rev Immunol (1990) 0.83
Longitudinal analysis of MART-1/HLA-A2-reactive T cells over the course of melanoma progression. Scand J Immunol (2003) 0.83
[Immunochemotherapy of malignant melanoma. Epifocal administration of dinitrochlorobenzene (DNCB) combined with systemic chemotherapy with dacarbazine (DTIC)]. Hautarzt (1998) 0.82
Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases. Br J Dermatol (1997) 0.82
Dendritic cell activation by danger and antigen-specific T-cell signalling. Exp Dermatol (2000) 0.80
Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study. Hum Gene Ther (1999) 0.80
Fotemustine given simultaneously with total brain irradiation in multiple brain metastases of malignant melanoma: report on a pilot study. Melanoma Res (1996) 0.79
Recurrent herpes simplex virus-induced erythema multiforme: different HLA-DQB1 alleles associate with severe mucous membrane versus skin attacks. Scand J Immunol (1998) 0.79
[Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature]. Hautarzt (1998) 0.79
Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis. J Invest Dermatol (1999) 0.78
TNF alpha interrupts antigen-presenting function of Langerhans cells by two mechanisms: loss of immunogenic peptides and impairment of antigen-independent T cell clustering. Adv Exp Med Biol (1995) 0.78
Isolation, enrichment, and culture of murine epidermal langerhans cells. Methods Mol Med (2001) 0.78
Severe bullous drug reactions treated successfully with cyclophosphamide. Br J Dermatol (1998) 0.77
[Nevus of Ota and choroid melanoma]. Hautarzt (2001) 0.75
Phospholipase A2 is secreted by murine keratinocytes after stimulation with IL-1 alpha and TNF-alpha. Arch Dermatol Res (1996) 0.75
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. J Mol Med (Berl) (1997) 0.75
Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma. Melanoma Res (1998) 0.75
Fluorescein-guided confocal laser endomicroscopy for the detection of ipilimumab-induced colitis. Endoscopy (2012) 0.75